Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil;Leçons opérationnelles tirées de la mise en œuvre pilote de Xpert MTB/RIF au Brésil

Bulletin of the World Health Organization

Volumn 92, Issue 8, 2014, Pages 613-617

  Durovni, Betina ^a   Saraceni, Valeria ^a   Cordeiro Santos, Marcelo ^b   Cavalcante, Solange ^a   Soares, Elizabeth ^a   Lourenço, Cristina ^c   Menezes, Alexandre ^d   van den Hof, Susan ^e   Cobelens, Frank ^f   Trajman, Anete ^g  

^a Health Secretariat of Rio de Janeiro City   (Brazil)

^b Tropical Medicine Foundation Dr Heitor Vieira Dourado   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Global Health Strategies   (Brazil)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^f AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; BRAZIL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFORMATION PROCESSING; MEDICAL INFORMATION SYSTEM; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PILOT STUDY; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; RAPID TEST; STAFF TRAINING; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; MICROBIOLOGY; PROCEDURES; SPUTUM; TUBERCULOSIS, PULMONARY;

HUMAN IMMUNODEFICIENCY VIRUS;

BRAZIL; HUMANS; INCIDENCE; PILOT PROJECTS; POLYMERASE CHAIN REACTION; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84905236134     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.131409     Document Type: Article

References (15)

1. Stop TB Partnership. Global Laboratory Initiative. Briefing Note: TB Diagnostics and Laboratory Strengthening [Internet]. Geneva: World Health Organization; 2014. Available from: http://www. stoptb. org/wg/gli/assets/documents/BRIEFING%20NOTE%20LABS%20for%20GC. pdf [cited 2014 Feb 14].
2. Global tuberculosis report 2012. Geneva: World Health Organization; 2013. Available from: http://www. who. int/tb/publications/global_report/en/[cited 2014 Feb 14].
3. Barreira D. Programa Nacional de Controle da Tuberculose [Internet]. Brasília: Ministry of Health, Brazil; 2013. Available from: https://docs. google. com/file/d/0B0CE2wqdEaR-VG1fa0JJMi1qa0U/edit [cited 2013 Mar 3]. Portuguese.
4. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363: 1005-15. doi: http://dx. doi. org/10. 1056/NEJMoa0907847 PMID: 20825313.
5. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect. 2012; 64: 580-8. doi: http://dx. doi. org/10. 1016/j. jinf. 2012. 02. 012 PMID: 22381459.
6. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014; 1: CD009593. PMID: 24448973.
7. Rapid implementation of the Xpert MTB/RIF diagnostic test. Geneva: World Health Organization; 2011. Available from: http://whqlibdoc. who. int/publications/2011/9789241501569_eng. pdf [cited 2013 Feb 28].
8. GAL-Gerenciador de Ambiente Laboratorial [Internet]. Sala: Ministério da Saúde; 2014. Available from: http://gal. datasus. gov. br/GAL/default. php]. [cited 2014 Feb 17]. Portuguese.
9. Toouli G, Georgiou A, Westbrook J. Changes, disruption and innovation: an investigation of the introduction of new health information technology in a microbiology laboratory. J Pathol Inform. 2012; 3: 16. doi: http://dx. doi. org/10. 4103/2153-3539. 95128 PMID: 22616028.
10. Telles MA da S, Menezes A, Trajman A. Bottlenecks and recommendations for the incorporation of new technologies in the tuberculosis laboratory network in Brazil. J Bras Pneumol. 2012; 38: 766-70. doi: http://dx. doi. org/10. 1590/S1806-37132012000600013 PMID: 23288123.
11. Stop TB Partnership. Implementation and roll-out of Xpert MTB/RIF. Update May 2013 [Internet]. Geneva: World Health Organization; 2013. Available from: http://www. stoptb. org/wg/gli/assets/documents/Xpert%20MTB-RIF%20UPDATE%20May%202013. pdf [cited 2014 Feb 17].
12. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011; 377: 1495-505. doi: http://dx. doi. org/10. 1016/S0140-6736(11)60438-8 PMID: 21507477.
13. Buntin MB, Burke MF, Hoaglin MC, Blumenthal D. The benefits of health information technology: a review of the recent literature shows predominantly positive results. Health Aff (Millwood). 2011; 30: 464-71. doi: http://dx. doi. org/10. 1377/hlthaff. 2011. 0178 PMID: 21383365.
14. Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med. 2006; 144: 742-52. doi: http://dx. doi. org/10. 7326/0003-4819-144-10-200605160-00125 PMID: 16702590.
15. Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, et al. Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. PLoS ONE. 2014; 9: e89301. doi: http://dx. doi. org/10. 1371/journal. pone. 0089301 PMID: 24586675.